Apremilast

Apremilast Reactions 1704, p49 - 2 Jun 2018 Acute weight loss: case report In a multi-centre retrospective study of 148 patients, one patient [age and sex not stated] was described, who developed acute weight loss during treatment with apremilast for plaque psoriasis [dosage, route and duration of treatment to reaction onset not stated]. The patient, who had plaque psoriasis, started receiving combination treatment with apremilast along with an unspecified therapy. Eventually, the patient developed significant acute weight loss, which required admission to the emergency department. Subsequently, the weight loss stabilised and the treatment with apremilast was continued. Author comment: "One patient receiving [combination therapy] experienced a severe [adverse event] was admitted to the emergency department on account of significant acute weight loss." "Efficacy . . . and safety (reported adverse events [AEs]) were assessed from baseline to week 16 (discontinuations were considered nonresponse)." Ighani A, et al. A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective study. Journal of the American Academy of Dermatology 78: 623-626, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1016/j.jaad.2017.09.060 - Canada 803323372 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Apremilast

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/apremilast-dArV7Nvpz5
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46692-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p49 - 2 Jun 2018 Acute weight loss: case report In a multi-centre retrospective study of 148 patients, one patient [age and sex not stated] was described, who developed acute weight loss during treatment with apremilast for plaque psoriasis [dosage, route and duration of treatment to reaction onset not stated]. The patient, who had plaque psoriasis, started receiving combination treatment with apremilast along with an unspecified therapy. Eventually, the patient developed significant acute weight loss, which required admission to the emergency department. Subsequently, the weight loss stabilised and the treatment with apremilast was continued. Author comment: "One patient receiving [combination therapy] experienced a severe [adverse event] was admitted to the emergency department on account of significant acute weight loss." "Efficacy . . . and safety (reported adverse events [AEs]) were assessed from baseline to week 16 (discontinuations were considered nonresponse)." Ighani A, et al. A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective study. Journal of the American Academy of Dermatology 78: 623-626, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1016/j.jaad.2017.09.060 - Canada 803323372 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off